Needle-free IV Connectors Market by Top Key players: Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc

The manufacturers of needle-free IV connectors are engaged in developing innovative products for the consumers. Manufacturers such as Becton, Dickinson and Company offers NeutraClear needle free connector with an orange indicator to reduce accidental removals with luers. Further, ICU Medical Inc. has its own patented technology of needle-free connector in which the connectors are silicon sealed to reduce the contact between connector's external and internal surface which further significantly reduces bacterial contamination. Asian countries such as India, China, and Indonesia have many local players of needle-free IV connectors. For example, in China there are more than 30 local players proving high quality needle-free connectors.

Depending on the internal characteristic and functioning of the parts, needle-free IV connectors are classified into simple and complex. The purpose of using needle-free IV connectors apart from ease in infusion for both care providers and patients, is to reduce the risk of needle-stick injuries during the surgeries among the health care providers and reducing the risk of bacterial and microbial contamination as they are disposable products.

Get Free Request PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/426

The global needle-free IV connectors' market size was valued at US$ 755.8 million in 2018 and is expected to exhibit a CAGR of 10.3% over the forecast period (2019-2027).

Rising risk of life-threatening diseases associated with blood stream infections is expected to propel demand of needle-free IV connectors

Improper use of syringes and needles causes various infections, diseases or deaths in some cases in hospitals and healthcare settings. Increasing number of blood borne diseases such hepatitis B & C and related deaths, owing to improper use of needles is expected to drive growth of the needle-free IV connectors market over the forecast period. For instance, according to the World Health Organization (WHO) data published in 2014, around 1.3 million deaths globally are reported each year due to improper use of syringes and needles, which can be prevented by adopting needle-free IV connectors. According to the same source, unsafe use of injections accounts for 5% of HIV, 40% of Hepatitis C, and 32% of Hepatitis B virus infections globally.

Moreover, the needle-free IV connector market is expected to witness significant growth in the forecast period, owing to increasing demand of needle-free IV connectors to prevent needle-stick injuries by healthcare workers. For instance, according to the Centers for Disease Control and Prevention (CDC) report of December 2013, around 385,000 needle stick injuries was accounted among healthcare workers in the U.S.

Restraining factors in the needle-free IV connectors market include product recalls due to product failures, component inconsistency, and lack of product handling knowledge, which are expected to hamper the global needle-free IV connectors' market growth over the forecast period. For instance, in May 2019, Becton Dickinson & Company's CareFusion MaxPlus Clear Needleless Connector was recalled by the U.S. FDA because of its loose fitting of the connector with the luer.

The loose fitting is expected to increase the risk of blood loss and formation of air embolism (air bubble) in the bloodstream that might harm the patient unpredictably, especially in the neonatal population. The manufacturer has initiated the recall but not all products have been removed and corrected.

Get Free Sample Copy of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/426

North America is expected to account for the largest share in the global needle-free IV connectors market, followed by Europe. This is mainly attributed to rising geriatric population and chronic diseases in North America. For instance, according to the Centers for Disease Control and Prevention (CDC), 2016, about 50% of adults of the U.S., accounting around 117 million people suffered from one or more chronic health conditions and one in every four adults suffered from two or more chronic health conditions.

The factors driving the growth of the needle-free IV connectors market includes government investments and funding to improve healthcare infrastructure, awareness about use of needle-free IV connectors among people and healthcare practitioners. For instance, in 2013, the National Healthcare Safety Network (NHSN) and Center for Disease Control and Prevention (CDC) has set up the guidelines for the prevention of central-line associated bloodstream infections. Further, CDC carried out surveillance methods to identify and track device-associated infections occurring in healthcare settings.

Furthermore, according to the World Health Organization (WHO), in 2014, chronic diseases were the leading cause of mortality in Europe with over one-third of the Europe population above the age of 15 suffered with a chronic disease and two out of every three people of age group of 60 suffered from at least two chronic conditions.

Key players operating in the global needle-free IV connectors market include Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon S.A.

Purchase Copy of This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/426

Media Contact:
Name: Mr. Raj Shah
Email: sales@coherentmarketinsights.com
Phone: US +12067016702
Country: United States
Website: https://www.coherentmarketinsights.com/

About Coherent Insights:
Coherent Insights is a prominent research and consulting firm offering action-ready syndicated research reports, custom analysis, consulting services, and competitive analysis through various recommendations related to emerging trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.